OPEN Feasibility Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03584412|
Recruitment Status : Active, not recruiting
First Posted : July 12, 2018
Last Update Posted : August 13, 2019
|Condition or disease||Intervention/treatment||Phase|
|HIV Neuropathy||Behavioral: ACT OPEN Other: Waiting list control||Not Applicable|
The human immunodeficiency virus (HIV) is a major health problem in the United Kingdom and worldwide. Neuropathic pain in the feet related to peripheral neuropathy is one of the most common symptoms associated with HIV. This pain is difficult to treat and medications are not effective. Chronic pain in people with HIV is related to higher levels of disability and poor quality of life.
Psychological treatments like cognitive behaviour therapy (CBT) can improve quality of life for people with chronic pain in general (not HIV-related), and there have been efforts to provide more accessible versions of CBT over the Internet. However, it is not known whether Internet-based CBT is helpful for people with HIV and chronic pain.
The current trial will explore the feasibility of a newly developed form of online CBT called Acceptance and Commitment Therapy (which we have called "ACT OPEN") for people with HIV and painful peripheral neuropathy. Participants will be recruited from HIV clinics in London, UK. Participants will be randomly chosen to receive the new ACT OPEN treatment right away or after waiting for 5 months. The treatment lasts for 8 weeks. Participants will complete self-report questionnaires to assess pain, functioning, and mood at the beginning of the study and 8 weeks and five months later.
The purpose of this study is to examine the feasibility of a larger trial evaluating the impact of online ACT for people with HIV and chronic pain in their feet. Key feasibility parameters that will be evaluated will include an estimate of the recruitment and retention rates, treatment completion rate and satisfaction, and an estimate of the effect size of changes in standard pain outcome measures.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||70 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||Participants will be randomly assigned to the ACT OPEN treatment condition immediately or following a 5 month wait using a 2:1 randomisation ratio (2: immediately; 1: waiting list control).|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Feasibility Randomized-Controlled Trial of Online Acceptance and Commitment Therapy for Painful Peripheral Neuropathy in People Living With HIV: The OPEN Feasibility Study|
|Actual Study Start Date :||July 9, 2018|
|Estimated Primary Completion Date :||December 31, 2019|
|Estimated Study Completion Date :||December 31, 2019|
Experimental: ACT OPEN
Acceptance and Commitment Therapy Online for Painful Peripheral Neuropathy (ACT OPEN).
Behavioral: ACT OPEN
Participants will access the ACT OPEN treatment through a secure online platform. Each session consists of brief videos and audio recordings that provide information about pain and guide participants through experiential exercises (e.g., mindfulness, values clarification, goal-setting). Participants will respond to questions assessing their experiences during the session and their progress using online messaging and/or brief telephone calls according to their preference. Therapists will provide individualised feedback. ACT OPEN consists of 12 sessions over 6 weeks. Participants will be given two further weeks to finish any uncompleted sessions, or to complete additional sessions (up to four) as agreed with their therapist.
Waiting List Control
Participants in this condition will not receive any change to their usual treatment for a period of 5 months, after which they will be given access to complete the ACT OPEN treatment.
Other: Waiting list control
Participants will receive their usual treatment for 5 months, after which they will complete ACT OPEN as described. A waiting list control was chosen as there is no clearly credible active psychotherapy to serve as the comparator in this context, particularly in light of high drop-out rates in two previous studies of CBT for pain in HIV. Providing the online treatment without therapist support may appear to be a logical comparison group instead of a waitlist control. However, there is evidence that therapist support is a key component of online CBT and, therefore, without this support it may not represent a credible treatment against which to judge the full treatment. In the context of the feasibility aims of this trial these reasons, the use of a waiting list control is thus justified.
- Recruitment Rate [ Time Frame: Baseline ]Proportion of participants randomised relative to total trial referrals
- Retention Rate [ Time Frame: 8 weeks post-randomisation ]Proportion of participants who complete follow-up questionnaires
- Treatment Completion Rate [ Time Frame: 8 weeks following receipt of treatment ]We expect 70% of participants to complete at least 8/12 ACT OPEN sessions
- Treatment Satisfaction [ Time Frame: 8 weeks following receipt of treatment ]Total score on the Client Satisfaction Questionnaire (range: 8-32; higher scores reflect greater satisfaction)
- Data Completeness [ Time Frame: Baseline ]Proportion of missing items on individual questionnaires
- Other Treatments Accessed [ Time Frame: 8 weeks post-randomisation ]Self-reported frequency of use of other treatments (e.g., medical, complimentary, etc)
- Patient's impression of overall change during treatment [ Time Frame: 8 weeks following receipt of treatment ]Score on single item Patient Global Impression of Change Rating (range: 1 (very much improved) to 7 (very much worse))
- Pain Interference [ Time Frame: 8 weeks post-randomisation ]Brief Pain Inventory average of pain interference subscale items score (range 0-10; higher scores reflect greater pain interference)
- Social and Occupational Functioning [ Time Frame: 8 weeks post-randomisation ]Work and Social Adjustment Scale Total Score (range: 0-40; higher scores reflect greater impairment in social and occupational functioning)
- Depression Symptoms [ Time Frame: 8 weeks post-randomisation ]PHQ-9 Total Score (range: 0-27; higher scores reflect more severe depression symptoms)
- Pain Acceptance [ Time Frame: 8 weeks post-randomisation ]Chronic Pain Acceptance Questionnaire--8 Item Version Total Score (range: 0-48; higher scores reflect greater acceptance)
- Pain Intensity [ Time Frame: 8 weeks post-randomisation ]Average of the Brief Pain Inventory pain intensity items (range: 0-10; higher scores reflect more intense pain)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03584412
|Chelsea and Westminster Hospital|
|London, United Kingdom, SE1 9RT|
|Guy's and St Thomas' Hospital NHS Foundation Trust|
|London, United Kingdom, SE1 9RT|
|King's College Hospital|
|London, United Kingdom, SE1 9RT|
|Principal Investigator:||Whitney Scott, PhD||Whitney Scott|